PACB

Pacific Biosciences of California Inc.

Price

$2.48

return (12m)

66.44%

p/e

-5.86

p/bv

-23.20

DIVIDEND YIELD

0.00%

PACB price

Pacific Biosciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment PACB

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

88.59%

3 months

49.39%

1 year

66.44%

2 years

52.15%

5 years

-89.82%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals PACB

Valuation

P/E

-5.86

Sector 1.27

Industry 8.57

P/BV

-23.20

Sector 1.88

Industry 3.63

P/Revenue (PSR)

4.84

Sector 1.56

Industry 3.09

EV/EBITDA

-30.95

Sector -46.85

Industry -17.98

EV/EBIT

-27.67

Sector -51.35

Industry -94.21

P/EBITDA

-7.30

Sector -31.66

Industry 7.07

P/EBIT

-6.25

Sector -43.19

Industry -32.11

P/Total Assets

1.02

Sector 0.87

Industry 1.32

P/Net Current Assets

-1.73

Sector -26.04

Industry -3.44

P/Working Capital

2.86

Sector -4.00

Industry 7.65

EPS

-0.42

Sector -0.70

Industry -0.23

BVPS

-0.11

Sector 4.48

Industry 8.61

Efficiency

Gross Margin

36.38%

Sector 49.44%

Industry 55.16%

EBITDA Margin

-97.55%

Sector -282.02%

Industry -13.47%

EBIT Margin

-109.14%

Sector -164.03%

Industry -25.89%

Operating Margin

-83.53%

Sector -19.60%

Industry -5.67%

Net Profit Margins

-82.49%

Sector -23.82%

Industry -7.67%

Asset Turnover

0.05

Sector 0.13

Industry 0.13

Profitability

ROE

395.59%

Sector -23.80%

Industry -24.00%

ROA

-17.48%

Sector -24.22%

Industry -5.96%

ROIC

-38.61%

Sector -587.47%

Industry -21.90%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

4.92

Sector 1.90

Industry 2.56

Net Debt / EBITDA

-10.71

Sector -23.34

Industry 9.41

Net Debt / EBIT

-9.57

Sector -11.26

Industry -2.82

Net Debt / Equity

-12.27

Sector -0.63

Industry -0.19

Gross Debt / Equity

-19.40

Sector -0.73

Industry 0.42

Equity/Assets

-0.04

Sector 0.46

Industry 0.50

Liabilities/Assets

1.04

Sector 0.50

Industry 0.53

Growth

5Y Revenue CAGR

4.06%

Sector -

Industry -

5Y Earnings CAGR

-6.23%

Sector -

Industry -

Fundamentals PACB

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
PACB Pacific Biosciences of California Inc.	$2.48	79.71%	0.00%	-5.86	-23.20	395.59%	-82.49%
ABT Abbott Laboratories	$96.56	-25.26%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$86.94	-4.56%	3.30%	21.10	2.17	10.29%	13.93%
BSX Boston Scientific Corp.	$42.80	-55.35%	0.00%	17.31	2.55	14.73%	17.49%
TMDX TransMedics Group Inc.	$77.58	-32.47%	0.00%	17.68	5.18	29.28%	22.69%
RMD ResMed Inc.	$220.18	-17.85%	1.12%	20.92	4.84	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$520.16	-16.12%	0.00%	36.04	25.47	70.67%	25.03%
COHR Coherent Inc.	$336.58	193.57%	0.00%	81.57	5.84	7.16%	11.31%
SYK Stryker Corp.	$275.16	-23.42%	1.27%	28.21	4.38	15.55%	14.43%
PHG Koninklijke Philips NV	$23.86	-10.29%	4.25%	17.60	1.72	9.80%	6.30%
INMD InMode Ltd.	$14.05	-8.08%	0.00%	10.69	1.32	12.32%	20.69%
BDX Becton Dickinson and Company	$176.01	-5.53%	2.39%	51.40	1.98	3.85%	6.29%
DXCM DexCom Inc.	$85.41	29.25%	0.00%	32.65	12.45	38.14%	20.12%
EW Edwards Lifesciences Corp.	$85.35	11.85%	0.00%	48.96	4.59	9.37%	15.43%
ALGN Align Technology Inc.	$145.01	13.72%	0.00%	25.13	2.46	9.77%	9.99%
SNN Smith & Nephew PLC	$26.32	-25.97%	2.96%	19.66	4.27	21.74%	9.20%
IRMD iRadimed Corporation	$85.25	22.44%	1.49%	47.27	10.71	22.66%	26.70%
ZBH Zimmer Biomet Holdings Inc.	$87.75	-10.09%	1.10%	20.85	1.33	6.39%	9.48%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

PACB - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Pacific Biosciences

Pacific Biosciences of California Inc.

Average Investor10 user rating

4.0 (3 people)

United States

26 years

Founded: 2000

2010

Time since IPO - 16 years

412

Employees

Pacific Biosciences of California Inc. (United States) is listed on the Nasdaq and has a market capitalization of $770.42 million, with shareholders equity totaling $-33.21 million.

The company employs approximately 412 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Pacific Biosciences of California Inc. reported $159.27 million in revenue, generating net income of $-131.39 million.

Key financial metrics include a P/E ratio of -5.86, a price-to-book (P/B) ratio of -23.20, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker PACB.

Market cap

$770.42 million

Net worth

$-33.21 million

$-33,213,000.00

Assets

$751.85 million

$751,850,000.00

Total Shares Outstanding

310.66 million

310,655,000

Average Daily Trading Volume

$9.68 million

$9,682,733.38

Sector

Health

Industry

Medical Supplies and Equipment

PACB

PACB revenue and profits

Financial Results PACB

DRAG THE FRAME TO SEE MORE DATA

PACB cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$86.67 15,38% (12M)

P/E

22.49

3.09%

ROE

6.12%

P/BV

1.38

CI - Cigna

$267.68 --11,99% (12M)

P/E

10.33

2.31%

ROE

16.04%

P/BV

1.66

CNC - Centene

$62.50 61,49% (12M)

P/E

-6.05

0.00%

ROE

-22.53%

P/BV

1.36

HUM - Humana

$383.17 37,00% (12M)

P/E

35.89

0.93%

ROE

6.63%

P/BV

2.38

SNY - Sanofi

$39.70 --18,93% (12M)

P/E

3.72

4.45%

ROE

18.43%

P/BV

0.69

JNJ - Johnson & Johnson

$255.81 38,68% (12M)

P/E

29.27

2.06%

ROE

24.76%

P/BV

7.25

LLY - Eli Lilly

$1,139.27 36,51% (12M)

P/E

38.06

0.59%

ROE

78.84%

P/BV

30.01

HCA - HCA Healthcare

$428.58 0,25% (12M)

P/E

13.82

0.71%

ROE

-213.15%

P/BV

-29.45